Lynx Dx
Jacob Meyers is an accomplished professional in the field of research and development, currently serving as Director of Research and Development at LynxDx since October 2022. Prior experience includes roles as Senior Scientist and Staff Scientist at Takara Bio USA, Inc. from September 2019 to October 2022, focusing on developing assays for reproductive health. Jacob's earlier work involved a postdoctoral fellowship at Texas A&M University, where research centered on the genetic basis of mosquito behavior using CRISPR/Cas9 techniques. Additionally, Jacob began their career as a Research Technician II at MPI Research, processing blood samples for GLP toxicology studies. Jacob holds a PhD in Biomedical Sciences from Colorado State University and a BA in Chemistry from Kalamazoo College.
This person is not in any teams
Lynx Dx
MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.